false
0001676163
IN
0001676163
2025-11-06
2025-11-06
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
Pursuant to Section 13 or 15(d) of The Securities
Exchange Act of 1934
Date of report (Date of earliest event reported):
November 6, 2025
SS INNOVATIONS INTERNATIONAL, INC.
(Exact name of registrant as specified in its charter)
| Florida |
|
001-42615 |
|
47-3478854 |
(State or Other Jurisdiction
of Incorporation) |
|
(Commission File Number) |
|
(IRS Employer
Identification No.) |
05, 3rd Floor, iLabs Info Technology Centre
Udyog Vihar, Phase III,
Gurugram, Haryana, India |
|
122016 |
| Address of Principal Executive Office (Street and Number) |
|
(Zip Code) |
Registrant’s telephone number, including
area code: +91 73375 53469
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
| ☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b)
of the Act:
| Title of each Class |
|
Trading Symbol |
|
Name of each exchange on which registered |
| Common Stock |
|
SSII |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ☐
As used in this Current Report on Form 8-K (this “Report”),
the terms “SSi,” “the Company,” “we,” “us” and “our”
refer to SS Innovations International, Inc. and its subsidiaries.
Item 7.01. Regulation FD Disclosure.
Attached hereto is an updated November 2025 Company
Presentation (the “Presentation”), which SSi intends to use in communications to shareholders and the investment community.
A copy of the Presentation is included with this
Report as Exhibit 99.1.
The information set forth in this Item 7.01
and in the Presentation included with this Report as Exhibit 99.1, are deemed to be “furnished” and shall not be deemed
to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”),
or otherwise subject to the liabilities of that Section. The information set forth in this Item 7.01 and in the Presentation included
with this Report as Exhibit 99.1, including without limitation, information accessed through the link set forth above, shall not
be deemed incorporated by reference into any filing under the Exchange Act or the Securities Act of 1933, as amended, regardless of any
general incorporation language in such filing.
Forward-Looking Statements
This Report may contain statements that are not
historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. The words
“anticipate,” “assume,” “believe,” “estimate,” “expect,” “will,”
“intend,” “may,” “plan,” “project,” “should,” “could,” “seek,”
“designed,” “potential,” “forecast,” “target,” “objective,” “goal,”
or the negatives of such terms or other similar expressions to identify such forward-looking statements. These statements relate to future
events or SSi’s future financial performance and involve known and unknown risks, uncertainties and other factors that may cause
our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity,
performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking
statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company’s
control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Some of the risks and
uncertainties, although not all risks and uncertainties, that could cause the Company’s actual results to differ materially from
those presented in its forward-looking statements are set forth in the Company’s Annual Report on Form 10-K, its Quarterly Reports
on Form 10-Q, and all of its other filings with the U.S. Securities and Exchange Commission, as such risks, uncertainties and other important
factors may be updated from time to time in the Company’s subsequent reports. Any forward-looking statement reflects our current
views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to SSi’s operations,
results of operations, growth strategy and liquidity.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
| Exhibit No. |
|
Description |
| 99.1* |
|
November 2025 Company Presentation |
| 104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
| * |
Furnished but not filed. |
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Dated: November 6, 2025 |
SS INNOVATIONS INTERNATIONAL, INC. |
| |
|
|
| |
By: |
/s/ Sudhir Srivastava |
| |
|
Sudhir Srivastava, M.D. |
| |
|
Chairman and Chief Executive Officer |
